Amphadase Amphastar Pharmaceuticals, Inc - Treatment for Adjunctive Agent
Amphadase (formulated as a replacement for Wydase which was discontinued in 2001) contains hyaluronidase, an enzyme that breaks down hyaluronic acid in connective tissue, increasing tissue permeability. Hyaluronidase is typically used as an adjunctive agent to facilitate the dispersion and absorption of other drugs.Posted: October 2004
Amphadase (hyaluronidase) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
